North Carolina Statutes
§ 90-325.32 — No liability to heirs for outstanding debt related to use of individualized investigational drugs, biological products, or devices
North Carolina § 90-325.32
This text of North Carolina § 90-325.32 (No liability to heirs for outstanding debt related to use of individualized investigational drugs, biological products, or devices) is published on Counsel Stack Legal Research, covering North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
N.C. Gen. Stat. § 90-325.32 (2026).
Text
If an eligible patient dies while being treated with an individualized investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment. (2024-36, s. 1.)
Free access — add to your briefcase to read the full text and ask questions with AI
Nearby Sections
15
§ 90-1.1
Definitions§ 90-10.1
Examinations accepted by the Board§ 90-100
Rules§ 90-105
Order forms§ 90-106
Prescriptions and labelingCite This Page — Counsel Stack
Bluebook (online)
North Carolina § 90-325.32, Counsel Stack Legal Research, https://law.counselstack.com/statute/nc/90/90-325.32.